{"id":1578,"date":"2020-10-05T08:26:10","date_gmt":"2020-10-05T08:26:10","guid":{"rendered":"https:\/\/doctorperezcabeza.com\/historial-academico-y-profesional\/"},"modified":"2024-12-04T12:57:16","modified_gmt":"2024-12-04T12:57:16","slug":"historial-academico-y-profesional","status":"publish","type":"page","link":"https:\/\/www.doctorperezcabeza.com\/en\/historial-academico-y-profesional\/","title":{"rendered":"Academic &amp; professional career"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#d73a5f&#8221; background_image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/cardiograma-1.svg&#8221; parallax=&#8221;on&#8221; width=&#8221;95%&#8221; module_alignment=&#8221;right&#8221; custom_padding=&#8221;4vw||0px||false|&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;||0px|||&#8221; custom_css_main_element=&#8221;align-items: flex-end;&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; custom_css_main_element_last_edited=&#8221;on|desktop&#8221;][et_pb_image src=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/doctor_alejandro_perez_cabeza_h.png&#8221; title_text=&#8221;Doctor Alejandro I. P\u00e9rez Cabeza&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; animation_style=&#8221;fade&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; text_font=&#8221;||||||||&#8221; text_font_size=&#8221;72px&#8221; text_line_height=&#8221;1.1em&#8221; header_font=&#8221;Gentium Basic|700|||||||&#8221; header_font_size=&#8221;70px&#8221; header_line_height=&#8221;1.2em&#8221; background_layout=&#8221;dark&#8221; custom_padding=&#8221;2px|||||&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;right&#8221; text_font_size_tablet=&#8221;&#8221; text_font_size_phone=&#8221;46px&#8221; text_font_size_last_edited=&#8221;on|phone&#8221; header_font_size_tablet=&#8221;40px&#8221; header_font_size_phone=&#8221;21px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; locked=&#8221;off&#8221; inline_fonts=&#8221;Playfair Display&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p class=\"color_light fw_light m_bottom_5\"><span face=\"Playfair Display\" style=\"font-family: 'Playfair Display';\">Academic and professional career<\/span><\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.16&#8243; text_font=&#8221;||||||||&#8221; text_font_size=&#8221;20px&#8221; text_line_height=&#8221;2em&#8221; header_font=&#8221;Gentium Basic|700|||||||&#8221; header_font_size=&#8221;70px&#8221; header_line_height=&#8221;1.2em&#8221; background_layout=&#8221;dark&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;right&#8221; text_font_size_tablet=&#8221;&#8221; text_font_size_phone=&#8221;15px&#8221; text_font_size_last_edited=&#8221;on|desktop&#8221; header_font_size_tablet=&#8221;40px&#8221; header_font_size_phone=&#8221;25px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>As well as providing medical and healthcare in daily clinical practice, I am passionate about other areas of my profession, like research (I participate in several working groups and clinical trials), teaching, and publication. The information below provides further details of my training and career. <\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;#expedienteacademico&#8221; button_text=&#8221;Academic curriculum&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_layout=&#8221;dark&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;right&#8221; animation_delay=&#8221;100ms&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_button button_url=&#8221;#actividadlaboral&#8221; button_text=&#8221;Work&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_layout=&#8221;dark&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;right&#8221; animation_delay=&#8221;200ms&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_button button_url=&#8221;#actividades&#8221; button_text=&#8221;Research activity&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_layout=&#8221;dark&#8221; custom_margin=&#8221;||60px|||&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;right&#8221; animation_delay=&#8221;300ms&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;About&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;||75px|||&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;bottom&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; text_font=&#8221;||||||||&#8221; text_font_size=&#8221;16px&#8221; text_line_height=&#8221;1.8em&#8221; header_font=&#8221;||||||||&#8221; header_2_font=&#8221;Gentium Basic|700|||||||&#8221; header_2_font_size=&#8221;50px&#8221; header_2_line_height=&#8221;1.2em&#8221; header_4_font=&#8221;Gentium Basic|700|||||||&#8221; header_4_font_size=&#8221;40px&#8221; header_4_line_height=&#8221;1.2em&#8221; text_orientation=&#8221;center&#8221; module_alignment=&#8221;center&#8221; header_2_font_size_tablet=&#8221;40px&#8221; header_2_font_size_phone=&#8221;25px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; header_4_font_size_tablet=&#8221;30px&#8221; header_4_font_size_phone=&#8221;22px&#8221; header_4_font_size_last_edited=&#8221;on|phone&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Academic and professional career<\/h2>\n<p>I hold a <strong><em>cum laude<\/em> doctorate<\/strong> from the University of Malaga and five different university qualifications (acute care in cardiology, cardiovascular prevention and cardiac rehabilitation, biomedical research in the healthcare context, expert in inherited cardiovascular diseases, and a master&#8217;s in heart failure). I have had articles published in the most prestigious specialist journals and I participate in both clinical trials and conferences.  <span style=\"font-size: 16px;\">I lead the Atrial Fibrillation Working Group and am <strong>Secretary of the Andalusian Society of Cardiology<\/strong>. My medical practice focuses on caring for patients with acute and chronic cardiovascular disease. I am a member of the <strong>Heart Failure and Inherited Heart Conditions Unit<\/strong> and the <strong>Head of Admissions for the Area of Cardiology <\/strong>  <em> <\/em>at Virgen de la Victoria University Hospital. <\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;3_4,1_4&#8243; module_id=&#8221;expedienteacademico&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||37px||false|false&#8221; custom_padding=&#8221;||75px|||&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;left&#8221; border_color_bottom=&#8221;#38c1c1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;3_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 class=\"p1\"><span class=\"s1\"><b>A) ACADEMIC QUALIFICATIONS<\/b><\/span><\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li class=\"p1\"><span class=\"s1\"><b>BACHELOR\u2019S DEGREE IN MEDICINE AND SURGERY<\/b>, M\u00e1laga University Medical Faculty (1994-2000)<br \/> Second highest grades in my year. <\/span><\/li>\n<li class=\"p1\"><span class=\"s1\"><b>DOCTORAL COURSE<\/b> in Internal Medicine, Malaga University Medical Faculty Course of 2001-2003  <\/span><\/li>\n<li class=\"p1\"><span class=\"s1\"><b>PhD IN MEDICINE<\/b>, M\u00e1laga University Medical Faculty. Reading and defence of Doctoral Thesis<br \/>16 December 2008, resulting in the award of OUTSTANDING and CUM LAUDE. <\/span><\/li>\n<li class=\"p1\"><span class=\"s1\"><b>DIPLOMA IN ADVANCED TRAINING IN LIFE SCIENCES RESEARCH<\/b> <br \/>(2007)<\/span><\/li>\n<li class=\"p1\"><span class=\"s1\"><b>APPLIED MASTER\u2019S postgraduate course<\/b> in distance learning in acute care in<br \/>Cardiology (01\/12\/2012-31\/07\/2014). Universidad Cat\u00f3lica San Antonio. <\/span><\/li>\n<li class=\"p1\"><span class=\"s1\"><b>APPLIED MASTER\u2019S postgraduate course<\/b> in cardiovascular prevention and cardiac rehabilitation (2016).<\/span><\/li>\n<li class=\"p1\"><span class=\"s1\"><b>I MASTER IN BIOMEDICAL RESEARCH IN THE HEALTHCARE CONTEXT <\/b>(2017-2018) University of M\u00e1laga  <\/span><\/li>\n<li><span><strong>EXPERT CERTIFICATION IN INHERITED CARDIOVASCULAR DISEASES (2020-2021). Francisco de Vitoria University, Madrid. <\/strong><\/span><span>(2020-2021). Universidad Francisco de Vitoria de Madrid.   <\/span><\/li>\n<li><span><strong>MASTER\u2019S IN HEART FAILURE<\/strong> (2022-2023). Rey Juan Carlos University <\/span><\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; prev_background_color=&#8221;#ffffff&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_video_mp4=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/web-cardiologo-alejandro-perez-cabeza-historial.mp4&#8243; height=&#8221;40vh&#8221; custom_padding=&#8221;||70px|||&#8221; top_divider_style=&#8221;slant&#8221; bottom_divider_style=&#8221;slant&#8221; bottom_divider_color=&#8221;#ffffff&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; prev_background_color=&#8221;#ffffff&#8221; next_background_color=&#8221;#ffffff&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#f0f7fa&#8221; background_image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/portafolio-2.svg&#8221; parallax=&#8221;on&#8221; custom_padding=&#8221;110px|||||&#8221; top_divider_style=&#8221;slant&#8221; bottom_divider_style=&#8221;slant&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_4,3_4&#8243; module_id=&#8221;actividadlaboral&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||37px||false|false&#8221; custom_padding=&#8221;||75px|||&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;right&#8221; border_color_bottom=&#8221;#38c1c1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;3_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 class=\"p1\"><span class=\"s1\"><b>B) PROFESSIONAL ACTIVITY<\/b><\/span><\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li class=\"p1\"><span class=\"s1\"><b>RESIDENCY IN CARDIOLOGY <\/b>at Virgen de la Victoria University Hospital, Malaga (20\/07\/01-20\/07\/06) <\/span><\/li>\n<li class=\"p2\"><span class=\"s1\">Specialist in Cardiology, <b>HOSPITAL PUNTA DE EUROPA <\/b>(20\/07\/06-04\/07\/08)<\/span><\/li>\n<li class=\"p2\"><span class=\"s1\">Specialist in Cardiology, <b>HOSPITAL COSTA DEL SOL<\/b> <b>PUBLIC COMPANY<\/b> (20\/07\/08-26\/07\/19)<\/span><\/li>\n<li class=\"p2\"><span class=\"s1\">Specialist in Cardiology, <b>VIRGEN DE LA VICTORIA UNIVERSITY HOSPITAL<\/b>, MALAGA (since 27\/07\/19)<\/span><span class=\"s1\"><\/span><\/li>\n<li class=\"p2\"><span class=\"s1\">Cardiologist at <b>HOSPITAL QUIR\u00d3N M\u00c1LAGA<\/b> (April 2010 to October 2020)<\/span><\/li>\n<li class=\"p2\"><span class=\"s1\">Cardiologist at <b>CENTRO M\u00c9DICO FUENGIROLA <\/b>(since April 2011)<\/span><\/li>\n<li class=\"p2\"><span class=\"s1\">Cardiologist at <b>VITHAS XANIT INTERNACIONAL HOSPITAL<\/b> (March 2020 to November 2022<\/span><\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][dica_divi_carousel show_items_mobile=&#8221;3&#8243; centermode=&#8221;on&#8221; loop=&#8221;on&#8221; autoplay=&#8221;on&#8221; scroller_effect=&#8221;on&#8221; dot_nav=&#8221;on&#8221; item_spacing=&#8221;67&#8243; equal_height=&#8221;on&#8221; dg_hash_nav=&#8221;on&#8221; advanced_effect=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][dica_divi_carouselitem admin_label=&#8221;Quir\u00f3n&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/20-logo-quiron.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/european-society-of-cardiologyx600.png&#8221; rating_position=&#8221;rating-under-title&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;max-width: 130px;||align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/hospital-xanit-logo.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/logo-hospital-clinico-universitario-virgen-de-la-victoria.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/Soc_Andaluza_.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/sociedad-SEC-cardiologia.png&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/Universidad-de-Santiago-de-Compostela.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/Universidad_de_M\u2020laga.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem admin_label=&#8221;Universitat oberta de catalunya&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/Universitat-Oberta-de-Catalunya.png&#8221; rating_position=&#8221;rating-under-title&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items: center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem admin_label=&#8221;Hospital universitario Virgen de la victoria&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/logo-1.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items:center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem admin_label=&#8221;IAVANTE&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/iavante_logo.png&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items:center;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem admin_label=&#8221;UMA logo&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/uma_logo.jpg&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;align-items:center;||max-width: 120px;&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][\/dica_divi_carousel][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||49px|||&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;bottom&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;3_5,2_5&#8243; module_id=&#8221;actividades&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|auto|19px|auto|false|false&#8221; custom_padding=&#8221;||0px|||&#8221; border_color_bottom=&#8221;#38c1c1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 class=\"p1\"><span class=\"s1\"><b>C) RESEARCH<span class=\"Apple-converted-space\">&#8211;<\/span>RELATED ACTIVITIES<\/b><\/span><\/h3>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|auto|0px|auto|false|false&#8221; custom_padding=&#8221;||32px|||&#8221; border_color_bottom=&#8221;#38c1c1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul class=\"ul1\">\n<li class=\"li1\"><span class=\"s1\"><\/span><span class=\"s2\"><b>PUBLICATIONS<\/b><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">-Clinical outcomes and mortality in patients with atrial fibrillation and recently diagnosed lung cancer in oncology outpatient setting. Piserra L\u00f3pez-Fern\u00e1ndez A, et al. Current problems in Cardiology. 2024;49(29).   <\/p>\n<p style=\"text-align: justify;\">-Adverse clinical outcomes and associated predictors in rivaroxaban-treated atrial fibrillation patients with renal impairment. S\u00e1nchez Caravaca JM, et al. The American Journal of Cardiology 2023;203:122-127.  <\/p>\n<p style=\"text-align: justify;\">-Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Mar\u00edn F, et al. Journal of Comparative Effectiveness Research, 2023; 12(3).  <\/p>\n<p style=\"text-align: justify;\">-Analysis of the activity of the telephone nursing consultation on demand for patient with heart failure. Cruzado Alvarez C, et al. Enfermer\u00eda cl\u00ednica, 2023;33(2):137-140  <\/p>\n<p style=\"text-align: justify;\">-Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. Esteve Pastor MA, et al. European Heart Journal Cardiovascular Pharmacotherapy 2022;9(1):38-46.  <\/p>\n<p style=\"text-align: justify;\">-Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions. G\u00f3mez Outes A, et al. Expert Opinion on Pharmacotherapy 2022;23(17):1941-1955.   <\/p>\n<p style=\"text-align: justify;\">-Una nueva mutaci\u00f3n en el gen ACTA 1, posiblemente asociada con miocardiopat\u00eda dilatada sin miopat\u00eda concomitante. D\u00edaz Exp\u00f3sito A, et al. Revista Espa\u00f1ola de Cardiolog\u00eda 2022;75(10): 851-853.   <\/p>\n<p style=\"text-align: justify;\">-Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018. D\u00edaz Guzm\u00e1n J, et al. Rev Esp Cardiol 2022;75(6).   <\/p>\n<p style=\"text-align: justify;\">-Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP-AF Long-term General Registry. Perez Cabeza AI, et al. Eur J Clin Invest 2022;52(4):e13709   <\/p>\n<p style=\"text-align: justify;\">-Mejorar la prevenci\u00f3n de la trombosis y las complicaciones cardiovasculares durante la pandemia de la COVID-19. Fern\u00e1ndez Lozano I, et al. Rev Esp Cardiol 2021;21(A):1-8  <\/p>\n<p style=\"text-align: justify;\">-Prevenci\u00f3n del ictus en pacientes con fibrilaci\u00f3n auricular. Mejorar la protecci\u00f3n en la era de la COVID-19. Masjuan Vallejo J, et al Rev Esp Cardiol 2021:21(A):9-17  <\/p>\n<p style=\"text-align: justify;\">-Impacto de los cambios en la prescripci\u00f3n del tratamiento anticoagulante en la incidencia de ictus. Freixa-Pamias R, P\u00e9rez Cabeza AI, Valle Mu\u00f1oz A et al. Rev Esp Cardiol:21(A):18-22  <\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Factores de predicci\u00f3n de dosificaci\u00f3n inadecuada de rivaroxab\u00e1n utilizando la ecuaci\u00f3n de CKD-EPI. P\u00e9rez Cabeza et al. Nefrolog\u00eda.  <\/span><span class=\"s3\"> <\/span><span class=\"s2\">DOI: 10.1016\/j.nefro.2020.04.016<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Recomendaciones de expertos en la mejora de la prevenci\u00f3n efectiva del ictus isqu\u00e9mico en la fibrilaci\u00f3n auricular no valvular. Papel de rivaroxaban. P\u00e9rez Cabeza et al. Rev. Esp Cardiol (aceptado publicaci\u00f3n 2020).    <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Clinical profile and management of rivaroxaban in patients with atrial fibrillation in routine practice in Spain: data from six nationwide studies. Anguita M et al. Drugs in context 2019;8:212606 DOI:10.7573\/dic.212606  <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis. P\u00e9rez Cabeza et al. Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):305-316. doi: 10.1016\/j.rec.2018.03.009.      <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-TIMI-AF score and cardiovascular events in vitamin K antagonists (VKA)-na\u00efve outpatients with atrial fibrillation. P\u00e9rez Cabeza, et al. Clin Cardiol 2018 Jul 30. doi: 10.1002\/clc.23035.    [Epub ahead of print]<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Perfil de pacientes con fibrilaci\u00f3n auricular no valvular tratados con rivaroxab\u00e1n en Espa\u00f1a: la desigualdad en el acceso a los anticoagulants orales directos (estudio HEROIC). Peris Vidal J et al. Cardiocore Junio 2018, in press. https:\/\/doi.org\/10.1016\/j.carcor.2018.04.002   <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Drug persistence and outcomes in a cohort of patients with nonvalvular atrial fibrillation treated with rivaroxaban after 2 years of follow-up in clinical practice. P\u00e9rez Cabeza et al. Future Cardiol 2018 May;14(3s):9-16. doi: 10.2217\/fca-2018-0021   <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Contemporary stroke prevention strategies in 11096 european patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. Boriani G, et al. Europace 2017 Sep 14:doi:10.1093\/europace\/eux301.  <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Discrepancias entre el empleo de las ecuaciones MDRD-4 IDMS y CKD-EPI, en vez de la ecuaci\u00f3n Cockcroft Gault, en la determinaci\u00f3n de la posologya de los anticoagulants orales directos en pacientes con fibrilaci\u00f3n auricular. P\u00e9rez Cabeza AI, Chinchurreta Capote PA, et al. Ted Clin (Barc) 2017 Jul 21. pii: S0025-7753(17)30472-4. doi: 10.10-Obstrucci\u00f3n din\u00e1mica intraventricular izquierda inducida por esfuerzo. Cabrera Bueno F, Rodr\u00edguez Bail\u00f3n I, L\u00f3pez Salguero R, et al. Rev Esp Cardiol 2004;57(12):1179-87.      <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Newly impaired glucose metabolism and prognosis after percutaneous revascularization. Jimenez-Navarro MF, Fern\u00e1ndez-Pastor J, Garrido-S\u00e1nchez L, Molina-Mora MJ, Ortiz-Garc\u00eda C, Alonso-Briales JH, P\u00e9rez-Cabeza A, Hern\u00e1ndez-Garc\u00eda JM, de Teresa-Galv\u00e1n E, Tinahones FJ. Cardiol J. 2014 Mar 27. Doi:10.5603\/CJ.a2104.0024.   <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Monitorizaci\u00f3n de la ablaci\u00f3n del istmo cavotricusp\u00eddeo. \u00c1lvarez M, P\u00e9rez-Cabeza A, Carretero J. Cardiocore 2014, 39:71. <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention. Jim\u00e9nez Navarro MF, et al. Int J Cardiol. 2010 Jul 23;142(3):245-249.   <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Tomograf\u00eda computarizada con multidetectores de venas coronarias y terapia de resincronizaci\u00f3n. Yris Flores, A. P\u00e9rez Cabeza, Rub\u00e9n Leta. Rev Esp Cardiol 2006; 59: 1070 \u2013 1070.  <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Disfunci\u00f3n ventricular sist\u00f3lica, un nuevo marcador de enfermedad coronaria en pacientes con estenosis a\u00f3rtica sin infarto de miocardio previo. P\u00e9rez Cabeza, G\u00f3mez Doblas, Morcillo Hidalgo, et al. Rev Esp Cardiol. 2005; 58 (2):218-21.16\/j.medcli.2017.06.003   <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul class=\"ul1\">\n<li class=\"li1\"><span class=\"s2\"><b>PARTICIPATION IN CLINICAL TRIALS\/REGISTRIES<\/b><\/span><\/li>\n<\/ul>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Co-investigator in the <b>CORONA <\/b>clinical trial (rosuvastatin versus placebo in patients with heart failure and severe ventricular dysfunction<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Co-investigator in the <b>STEEPLE<\/b> clinicl trial (Intravenous low molecular weight heparin or unfractionated heparin sodium in percutaneous coronary catheterisation for patients undergoing coronary angioplasty and\/or coronary stent implantation).<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>M\u00c1SCARA <\/b>registry (prevalence of acute coronary syndrome in various Spanish hospitals).<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>PREFER in AF <\/b>registry (European Multi-nation Registry on the Prevention of Thromboembolic Events in Atrial Fibrillation).<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>FANTASIIA <\/b>registry (Atrial fibrillation: Influence of anticoagulation level and type on stroke and bleeding event incidence). <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>EURObservational Research Programme<\/b>. Long-term registry of patients with atrial fibrillation.  <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>GLORIA-AF 3:<\/b> Global registry on long\u2010term oral antithrombotic treatment in patients with atrial fibrillation. <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>ESTUDIO HEROIC<\/b>: cross-sectional, observational study to assess the sociodemographic and clinical characteristics of patients treated with rivaroxaban in habitual clinical practice of haematologists, cardiologists and internists countrywide. Code: BAY-RIV-2014-01.  <\/span><span class=\"s3\">Regional Coordinator for Eastern Andalusia.<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-Non-interventional study on treatment with edoxaban in habitual clinical practice for patients with nonvalvular atrial fibrillation (<b>ETNA-AF-Europe<\/b>) <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>EMIT AF\/VTE<\/b>:<br \/>Management of edoxaban in diagnostic and therapeutic procedures. Registry number: DSE-EDO-02-15  <\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>ESTUDIO EMIR<\/b>: An observational study to identify risk factors associated with <br \/> major cardiovascular events in patients with nonvalvular atrial fibrillation treated with a direct oral anticoagulant (rivaroxaban). <\/span><span class=\"s3\">Regional Coordinator for Eastern Andalusia.<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">-ENSAYO CLINICO <b>AUGUSTUS<\/b> (BMS CV185-316): Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.<\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>PACIFIC AF <\/b>clinical trial (BAY 2433334 \/ 19765): Randomised, double-blind, phase 2 dose-finding multi-centre clinical trial with active treatment control, double dummy and parallel groups to compare the safety of the oral inhibitor FXIa BAY 2433334 with apixaban in patients with atrial fibrillation.<\/span><br \/><span class=\"s2\"><\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\">&#8211; <strong>OCEANIC AF<\/strong> clinical trial: A multi-centre, international, randomised, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm Phase III study investigating asundexian compared to apixaban in patients with atrial fibrillation at risk for stroke to determine the safety and efficacy of asundexian on prevention of stroke and systemic embolism <span class=\"s2\"><\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\">&#8211;<strong>LIBREXIA-AF <\/strong>clinical trial: A Phase 3, randomised, double-dummy, parallel group, active controlled study to evaluate the efficacy and safety of milvexian, an oral factor XIa Inhibitor, versus apixaban in participants with atrial fibrillation.<span class=\"s2\"><\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\">&#8211;<b>EMPULSE <\/b>clinical trial: A multi-centre, randomised, double-blind, 90-day superiority trial to evaluate the effect on clinical benefit, safety and tolerability of once daily oral empagliflozin 10 mg compared to a placebo, initiated in patients hospitalised for acute heart failure (de novo or decompensated chronic HF) who have been stabilised.<\/span><\/p>\n<p style=\"text-align: justify;\">&#8211;<strong>FINEART HF<\/strong> clinical trial: A multi-centre, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction \u2265 40% (LVEF \u2265 40%)<\/p>\n<p style=\"text-align: justify;\">&#8211;<strong>DIAMOND<\/strong> clinical trial: Patiromer for the management of hyperkalemia in subjects receiving RAASi medications for the treatment of heart failure..<\/p>\n<p style=\"text-align: justify;\">&#8211;<strong>HELIOS-B clinical trial<\/strong>: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy<\/p>\n<p style=\"text-align: justify;\">&#8211;<strong>PANDORA <\/strong>study: An observational ambidirectional study to analyse the evolutionary management of drugs with a prognostic effect on patients treated with the polypill as basic treatment on discharge after a first acute coronary syndrome.<\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\"><\/span><\/p>\n<p class=\"p3\" style=\"text-align: justify;\"><span class=\"s2\"><\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||37px||false|false&#8221; custom_padding=&#8221;||75px|||&#8221; border_color_bottom=&#8221;#38c1c1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul class=\"ul1\">\n<li class=\"li1\"><span class=\"s1\"><\/span><span class=\"s2\"><b>PARTICIPATION AS CONFERENCE SPEAKER<\/b><\/span><span class=\"s1\"><\/span><\/li>\n<\/ul>\n<p class=\"p1\"><span class=\"s1\">I have participated in conferences as a speaker on over 50 occasions, mostly on subjects related <br \/>to the field of oral anticoagulants in atrial fibrillation.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\"><\/span><\/p>\n<p class=\"p3\"><span class=\"s1\"><b>D) TEACHING<\/b><\/span><\/p>\n<p class=\"p4\"><span class=\"s1\"><b><\/b><\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">I have undertaken different teaching responsibilities, foremost among which are:<\/span><\/p>\n<p class=\"p1\">&#8211;<strong>Tutor of cardiology residents<\/strong> at Virgen de la Victoria Hospital since 2022.<span class=\"s1\"><\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">&#8211; <strong>Clinical practice tutor <\/strong>(<strong>Malaga University Medical Faculty<\/strong>) teacher\/trainer in clinical practice 2013 to date.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">-Author of training materials for postgraduate training course, Universitat Oberta de Catalunya.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">-Lecturer, postgraduate expert course in ATRIAL FIBRILLATION (continuous postgraduate training). Author of the chapter: \u201cNatural history and the possibilities of prevention\u201d. University of Santiago de Compostela Spanish Society of Cardiology April-October 2014.    <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">-Lecturer, courses in \u201cExpert Management of Echocardiography\u201d organised by IAVANTE, the Foundation for Technological Advance and Professional Training.<\/span><\/p>\n<p class=\"p1\">-Training activity educator, \u201cManagement of atrial fibrillation patients in the hospital healthcare environment\u201d, organised by IAVANTE (2024). <span class=\"s1\"><\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">-Coordinator of theory-practical courses in echocardiography given at Hospital de Alta Resoluci\u00f3n, Benalmadena (2011.2012 and 2013).<\/span><\/p>\n<p class=\"p1\">-Lecturer, Master in Echocardiography, Universidad Cat\u00f3lica de Murcia<span class=\"s1\"><\/span><\/p>\n<p class=\"p5\"><span class=\"s1\"><\/span><\/p>\n<p class=\"p3\"><span class=\"s1\"><b>E) OTHER ROLES<\/b><\/span><\/p>\n<p class=\"p4\"><span class=\"s1\"><\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">&#8212;<strong>Head of Admissions<\/strong>, Heart Area, Virgen de la Victoria University Hospital since October 2024.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">&#8211;<strong>Secretary <\/strong>of the <strong>Andalusian Society of Cardiology<\/strong> (2024-2027)<\/span><\/p>\n<p class=\"p1\">-Member of the <strong>Spanish National Cardiology Commission<\/strong> since 2024.<span class=\"s1\"><\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">&#8211;<strong>President of the Andalusian Society of Cardiology\u2019s Atrial Fibrillation Working Group<\/strong> since May 2019.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">-Chair of the <strong>SEC-Excelente<\/strong>-Proceso Atrial Fibrillation Working Group of the Andalusian Society of Cardiology since May 2019.<\/span><\/p>\n<p class=\"p1\">-Member of the <strong>CIBERCV <\/strong>Research Group led by Dr. Jim\u00e9nez Nav<span class=\"s1\"><\/span><\/p>\n<p class=\"p1\">&#8211;<strong>Coordinator <\/strong>of the <strong>Healthcare Process for Atrial Fibrillation and <em>Flutter <\/em><\/strong>of the Andalusian Regional Government\u2019s Health Department <\/p>\n<p class=\"p1\">-Voting member of the Virgen de la <strong>Victoria University Hospital Multi-disciplinary Commission<\/strong> for the Rational Use of Medicines since 2024<\/p>\n<p class=\"p1\"><span class=\"s1\">-Voting member and Vice-president of the <strong>Costa del Sol Hospital Ethics Committee<\/strong> for Scientific Research<span class=\"Apple-converted-space\"> <\/span>(2013-2019).<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">-Member of the Costa del Sol <strong>Hospital Medical Records Commission<\/strong> (2012).<\/span><\/p>\n<p class=\"p1\">-Member of the Virgen de la Victoria <strong>Hospital Protocols Commission <\/strong>(2021.<span class=\"s1\"><\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">&#8211;<strong>Coordinator <\/strong>of the Virgen de la Victoria Hospital<strong> Atrial Fibrillation process,<\/strong> certified in 2020 by Spanish Society of Cardiology\u2019s SEC-Excelente project.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">&#8211;Member of the <strong>Andalusian Society of Cardiology<\/strong>, the <strong>Spanish Society of Cardiology<\/strong> and the <strong>European Society of Cardiology<\/strong>.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.6.6&#8243; _module_preset=&#8221;default&#8221; background_image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/electrocardiograma2.jpg&#8221; parallax=&#8221;on&#8221; min_height=&#8221;515px&#8221; custom_margin=&#8221;-4px||||false|false&#8221; custom_padding=&#8221;17px|||||&#8221; global_module=&#8221;960&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/calendario.svg&#8221; title_text=&#8221;calendar&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;120px&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_cta title=&#8221;Ask for a consultation&#8221; button_url=&#8221;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjU0NiJ9fQ==@&#8221; button_text=&#8221;Ask for a consultation&#8221; _builder_version=&#8221;4.16&#8243; _dynamic_attributes=&#8221;button_url&#8221; _module_preset=&#8221;default&#8221; header_font_size=&#8221;38px&#8221; body_font_size=&#8221;21px&#8221; body_line_height=&#8221;1.6em&#8221; background_color=&#8221;rgba(0,0,0,0)&#8221; custom_margin=&#8221;||18px|||&#8221; custom_padding=&#8221;||7px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>If you would like to contact me for a consultation, please send me a message. I\u2019ll be in touch as soon as possible. I\u2019ll be in touch as soon as possible.<\/p>\n<p>[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; module_id=&#8221;material-carousel&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#d73a5f&#8221; custom_padding=&#8221;100px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.16&#8243; text_font=&#8221;Playfair Display||||||||&#8221; text_text_color=&#8221;#ffffff&#8221; header_font=&#8221;Playfair Display||||||||&#8221; header_text_align=&#8221;center&#8221; header_2_font=&#8221;Poppins||||||||&#8221; header_2_text_align=&#8221;center&#8221; header_2_font_size=&#8221;34px&#8221; custom_margin=&#8221;||18px|||&#8221; custom_padding=&#8221;||0px|||&#8221; inline_fonts=&#8221;Playfair Display&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2><span style=\"font-family: 'Playfair Display'; color: #ffffff;\">Major Publications<\/span><\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][dica_divi_carousel show_items_desktop=&#8221;3&#8243; show_items_tablet=&#8221;1.5&#8243; show_items_mobile=&#8221;2&#8243; transition_duration=&#8221;1000&#8243; centermode=&#8221;on&#8221; loop=&#8221;on&#8221; autoplay=&#8221;on&#8221; arrow_nav=&#8221;on&#8221; item_spacing=&#8221;8&#8243; advanced_effect=&#8221;coverflow&#8221; coverflow_rotate=&#8221;0&#8243; arrow_show_hover=&#8221;on&#8221; innercontent_padding=&#8221;40px|30px|40px|30px|true|true&#8221; _builder_version=&#8221;4.16&#8243; title_font=&#8221;PT Sans Caption|700|||||||&#8221; title_text_color=&#8221;#202121&#8243; title_font_size=&#8221;15px&#8221; body_font=&#8221;PT Sans Caption||||||||&#8221; body_text_color=&#8221;#202121&#8243; body_font_size=&#8221;13px&#8221; global_colors_info=&#8221;{}&#8221;][dica_divi_carouselitem title=&#8221;Dilemas en la prescripci\u00f3n de los anticoagulantes orales de acci\u00f3n directa en la fibrilaci\u00f3n auricular no valvular&#8221; button_url=&#8221;#&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/revista_cardiologia_1.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#fcfcfc&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;13px&#8221; button_text_color=&#8221;#202121&#8243; button_border_width=&#8221;0px&#8221; button_font=&#8221;PT Sans Caption||||||||&#8221; button_use_icon=&#8221;on&#8221; button_on_hover=&#8221;off&#8221; button_alignment=&#8221;right&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221; button_text_color__hover_enabled=&#8221;on&#8221; button_text_color__hover=&#8221;#313d9f&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Factores de predicci\u00f3n de dosificaci\u00f3n inadecuada de rivaroxab\u00e1n utilizando la ecuaci\u00f3n de CKD-EPI&#8221; button_url=&#8221;#&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/revista_nefrologia_2.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#fcfcfc&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;13px&#8221; button_text_color=&#8221;#202121&#8243; button_border_width=&#8221;0px&#8221; button_font=&#8221;PT Sans Caption||||||||&#8221; button_use_icon=&#8221;on&#8221; button_on_hover=&#8221;off&#8221; button_alignment=&#8221;right&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Cardiocore&#8221; button_url=&#8221;#&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/CARDIOCORE.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#fcfcfc&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;13px&#8221; button_text_color=&#8221;#202121&#8243; button_border_width=&#8221;0px&#8221; button_font=&#8221;PT Sans Caption||||||||&#8221; button_use_icon=&#8221;on&#8221; button_on_hover=&#8221;off&#8221; button_alignment=&#8221;right&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Newly impaired glucose metabolism and prognosis after percutaneous revascularization&#8221; button_url=&#8221;#&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/revista_via_medica.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#fcfcfc&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;13px&#8221; button_text_color=&#8221;#202121&#8243; button_border_width=&#8221;0px&#8221; button_font=&#8221;PT Sans Caption||||||||&#8221; button_use_icon=&#8221;on&#8221; button_on_hover=&#8221;off&#8221; button_alignment=&#8221;right&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;TIMI-AF score and cardiovascular events in vitamin K antagonists-na\u00efve outpatients with atrial fibrillation&#8221; button_url=&#8221;#&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/revista_more_data_1.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#fcfcfc&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;13px&#8221; button_text_color=&#8221;#202121&#8243; button_border_width=&#8221;0px&#8221; button_font=&#8221;PT Sans Caption||||||||&#8221; button_use_icon=&#8221;on&#8221; button_on_hover=&#8221;off&#8221; button_alignment=&#8221;right&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Drug persistence and outcomes in a cohort of patients with nonvalvular atrial fibrillation treated with rivaroxaban after 2 years of follow-up in clinical practice&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/revista_future_cardiology.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#fcfcfc&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Perfil de pacientes con fibrilaci\u00f3n auricular no valvular tratados con rivaroxaban en Espan\u00f1a: la desigualdad en el acceso a los anticoagulantes orales directos (estudio HEROIC)&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/revista_cardiocore_2.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#fcfcfc&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Medicina Cl\u00ednica&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/MEDICINA-CLINICA.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#fcfcfc&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Anticoagulantes orales directos frente a antagonistas de la vitamina K en pacientes con fibrilaci\u00f3n auricular de la pr\u00e1ctica cl\u00ednica: revisi\u00f3n sistem\u00e1tica y metan\u00e1lisis&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/carlos_escobar.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#fcfcfc&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Nefrolog\u00eda&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/revista_nefrologia_3.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#fcfcfc&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][dica_divi_carouselitem title=&#8221;Revista cardiol\u00f3gica&#8221; button_url_new_window=&#8221;1&#8243; image=&#8221;https:\/\/www.doctorperezcabeza.com\/wp-content\/uploads\/2020\/11\/REC-METAANALISIS-ESCOBAR.jpg&#8221; content_padding=&#8221;20px|20px|20px|20px|true|true&#8221; button_margin=&#8221;-25px|10px|0|0&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#fcfcfc&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/dica_divi_carouselitem][\/dica_divi_carousel][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Academic and professional careerAs well as providing medical and healthcare in daily clinical practice, I am passionate about other areas of my profession, like research (I participate in several working groups and clinical trials), teaching, and publication. The information below provides further details of my training and career. Academic and professional career I hold a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":70,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-1578","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/pages\/1578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/comments?post=1578"}],"version-history":[{"count":6,"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/pages\/1578\/revisions"}],"predecessor-version":[{"id":1677,"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/pages\/1578\/revisions\/1677"}],"wp:attachment":[{"href":"https:\/\/www.doctorperezcabeza.com\/en\/wp-json\/wp\/v2\/media?parent=1578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}